Shanghai Bio-heart Biological Technology Co (HKSE:02185) EBITDA Margin % : 0.00% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai Bio-heart Biological Technology Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shanghai Bio-heart Biological Technology Co's EBITDA for the six months ended in Jun. 2024 was HK$-26.15 Mil. Shanghai Bio-heart Biological Technology Co's Revenue for the six months ended in Jun. 2024 was HK$0.00 Mil. Therefore, Shanghai Bio-heart Biological Technology Co's EBITDA margin for the quarter that ended in Jun. 2024 was 0.00%.

Shanghai Bio-heart Biological Technology Co EBITDA Margin % Historical Data

The historical data trend for Shanghai Bio-heart Biological Technology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Bio-heart Biological Technology Co EBITDA Margin % Chart

Shanghai Bio-heart Biological Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Shanghai Bio-heart Biological Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBITDA Margin %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Shanghai Bio-heart Biological Technology Co's EBITDA Margin %

For the Biotechnology subindustry, Shanghai Bio-heart Biological Technology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Bio-heart Biological Technology Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Bio-heart Biological Technology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai Bio-heart Biological Technology Co's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Shanghai Bio-heart Biological Technology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Shanghai Bio-heart Biological Technology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-182.537	/	0
	=	%

Shanghai Bio-heart Biological Technology Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-26.147	/	0
	=	%

Shanghai Bio-heart Biological Technology Co (HKSE:02185) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Shanghai Bio-heart Biological Technology Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Shanghai Bio-heart Biological Technology Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Bio-heart Biological Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.590 Ruiqing Road, Room 302, 3rd Floor, Building 4 & Building 6, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

http://www.bio-heart.com

Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension.

Executives

Tpg Operating Group Ii, L.p.	2201 Interest of corporation controlled by you
Chen Hao	2201 Interest of corporation controlled by you
Zhu Linan	2201 Interest of corporation controlled by you
Wang Nengguang	2201 Interest of corporation controlled by you
Union Season Holdings Limited	2201 Interest of corporation controlled by you
Sk China Company Limited	2201 Interest of corporation controlled by you
Right Lane Limited	2201 Interest of corporation controlled by you
Proud Solar Limited	2201 Interest of corporation controlled by you
Magic Grace Limited	2101 Beneficial owner
Loft Success Investments Limited	2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii, L.p.	2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii Gp Limited	2201 Interest of corporation controlled by you
Lc Fund Gp Limited	2201 Interest of corporation controlled by you
Great Unity Fund I, L.p.	2201 Interest of corporation controlled by you
Lian Xiang Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

Shanghai Bio-heart Biological Technology Co Headlines

No Headlines